Read the latest positive news, breakthroughs, and inspiring stories about leukemia treatment, curated daily by BrightWire.
Three scientists from France and China turned one of the deadliest forms of leukemia into one of the most curable, saving thousands of lives worldwide. Their 30-year collaboration combined Western and Chinese medicine to achieve a 90% survival rate.
A three-drug combination therapy achieved nearly 90% response rates in patients with a hard-to-treat form of leukemia that had returned after standard treatments failed. The treatment worked fast and was well tolerated, offering new hope for people facing limited options.
Karen Bohn had six days to live when doctors diagnosed her rare leukemia in 2019. Thanks to a treatment breakthrough funded by decades of research, she's now five years cancer-free and celebrating at the tournament that helped save her life.
Australian scientists are launching a five-year program to help more leukemia patients stop treatment permanently. Only one in three chronic myeloid leukemia patients can safely quit therapy today, but new research aims to change that.
Scientists discovered a protein that could help transform stubborn leukemia cells into healthy white blood cells that die naturally. The breakthrough could offer hope for patients with the most aggressive forms of blood cancer.
%252c_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg)
Scientists at MD Anderson Cancer Center discovered an experimental therapy that stops aggressive leukemia cells even after they've become resistant to standard treatments. The breakthrough could help patients with the deadliest forms of blood cancer who have run out of options.
A new targeted therapy for chronic myeloid leukemia achieved major molecular responses in nearly half of patients with advanced disease. The drug, ELVN-001, performed even better in patients treated earlier, offering fresh hope in the fight against this slow-growing blood cancer.
Google's new AI system just helped discover promising leukemia treatments that actually worked in laboratory experiments. This isn't science fiction anymore—it's real progress happening right now in cancer research.
A husband-and-wife research team turned their midnight lab conversations at the University of Virginia into ziftomenib, a newly FDA-approved drug now saving lives of leukemia patients who had run out of options. Their 17-year journey from academic research to life-saving treatment shows how university labs can tackle diseases others overlook.
When Britt Mayo was diagnosed with leukemia in 2010, one conversation about his life priorities helped him avoid chemotherapy and qualify for a trial that led to remission. Now he's helping other patients learn they have choices in their cancer care.
Scientists in China have discovered how to turn a single stem cell into 14 million powerful cancer fighters, potentially making lifesaving treatment available to thousands more patients. The breakthrough slashes costs and could transform how we treat leukemia and other cancers.
Researchers at Monash University have found a way to permanently silence cancer-causing genes in aggressive leukemias, potentially allowing shorter treatment courses with fewer side effects. The discovery targets the cellular "memory" that keeps cancer genes switched on.